Published in MMWR Morb Mortal Wkly Rep on February 25, 2022
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol (2006) 10.21
Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis (2012) 8.02
Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. J Clin Microbiol (2005) 7.91
The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med (2004) 6.32
Persistence of Ebola Virus in Ocular Fluid during Convalescence. N Engl J Med (2015) 5.92
Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med (2014) 5.74
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep (2005) 5.70
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep (2006) 5.63
Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis (2002) 5.23
Ebola 2014--new challenges, new global response and responsibility. N Engl J Med (2014) 5.23
Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev (2006) 5.13
Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis (2002) 5.09
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia. PLoS Pathog (2007) 4.82
Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med (2014) 4.79
Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med (2007) 4.69
Estimating the future number of cases in the Ebola epidemic--Liberia and Sierra Leone, 2014-2015. MMWR Surveill Summ (2014) 4.53
A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol (2005) 4.48
Laboratory efforts to cultivate noroviruses. J Gen Virol (2004) 4.41
An outbreak of hepatitis A associated with green onions. N Engl J Med (2005) 3.89
Clinical responses to undiluted and diluted smallpox vaccine. N Engl J Med (2002) 3.86
Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med (2011) 3.78
Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2006) 3.77
Ebola virus disease in West Africa--clinical manifestations and management. N Engl J Med (2014) 3.73
Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis (2007) 3.47
Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens. J Virol (2003) 3.15
Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol (2004) 2.83
Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice. Nature (2013) 2.80
Factors associated with fulminant liver failure during an outbreak among injection drug users with acute hepatitis B. Hepatology (2004) 2.78
Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) (2002) 2.75
Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy. AIDS (2006) 2.71
Changing trends in hepatitis C-related mortality in the United States, 1995-2004. Hepatology (2008) 2.66
Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues. J Infect Dis (2010) 2.64
A computational genomics pipeline for prokaryotic sequencing projects. Bioinformatics (2010) 2.63
Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003) 2.59
Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Vaccine (2007) 2.51
Monkeypox transmission and pathogenesis in prairie dogs. Emerg Infect Dis (2004) 2.45
Noroviruses everywhere: has something changed? Curr Opin Infect Dis (2006) 2.44
Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. J Infect Dis (2006) 2.43
The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis (2005) 2.43
Incidence of hepatitis A in the United States in the era of vaccination. JAMA (2005) 2.42
Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology (2005) 2.36
Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J Virol (2003) 2.36
Norwalk virus infection associates with secretor status genotyped from sera. J Med Virol (2005) 2.34
Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. Blood (2008) 2.27
A tale of two clades: monkeypox viruses. J Gen Virol (2005) 2.24
Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology (2005) 2.24
The immunogenetics of smallpox vaccination. J Infect Dis (2007) 2.23
Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis (2010) 2.21
Hepatitis C virus transmission from an anesthesiologist to a patient. Arch Intern Med (2002) 2.11
Proteome-wide analysis of the serological response to vaccinia and smallpox. Proteomics (2007) 2.10
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection. N Engl J Med (2016) 2.09
Ethical and practical considerations in providing critical care to patients with Ebola virus disease. Chest (2015) 2.05
A 68-Year-Old Musician With Cough, Wheezing, and a Lung Mass. Chest (2015) 2.00
A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers. J Infect Dis (2011) 1.99
In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients. J Clin Invest (2005) 1.96
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial. Lancet Infect Dis (2013) 1.95
Detection of bacterial pathogens in Mongolia meningitis surveillance with a new real-time PCR assay to detect Haemophilus influenzae. Int J Med Microbiol (2011) 1.94
Clinical presentation of nipah virus infection in Bangladesh. Clin Infect Dis (2008) 1.91
Extended interhuman transmission of monkeypox in a hospital community in the Republic of the Congo, 2003. Am J Trop Med Hyg (2005) 1.91
Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy. J Virol (2009) 1.84
Genome sequence diversity and clues to the evolution of variola (smallpox) virus. Science (2006) 1.84
On the origin of smallpox: correlating variola phylogenics with historical smallpox records. Proc Natl Acad Sci U S A (2007) 1.84
Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functions. J Infect Dis (2005) 1.84
Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J Infect (2005) 1.83
Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies. Vaccine (2003) 1.83
IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation. Blood (2004) 1.82
Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients. J Clin Invest (2005) 1.82
Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons. J Infect Dis (2012) 1.80
The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature (2013) 1.78
Detection of monkeypox virus with real-time PCR assays. J Clin Virol (2006) 1.77
Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax. J Virol (2007) 1.77
Hepatitis A in the era of vaccination. Epidemiol Rev (2006) 1.75
Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials. HIV Clin Trials (2010) 1.75
High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med (2002) 1.74
Real-time PCR system for detection of orthopoxviruses and simultaneous identification of smallpox virus. J Clin Microbiol (2004) 1.74
Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial. J Acquir Immune Defic Syndr (2007) 1.73
Noroviruses: The leading cause of gastroenteritis worldwide. Discov Med (2010) 1.73
Clinical manifestations of human monkeypox influenced by route of infection. J Infect Dis (2006) 1.71
Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol (2010) 1.69
Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. Arch Intern Med (2006) 1.68
Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles. J Infect Dis (2011) 1.67
Monkeypox zoonotic associations: insights from laboratory evaluation of animals associated with the multi-state US outbreak. Am J Trop Med Hyg (2007) 1.67
Norwalk virus RNA is infectious in mammalian cells. J Virol (2007) 1.66
Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis (2009) 1.66
Determination of the underlying cause of death in three multicenter international HIV clinical trials. HIV Clin Trials (2008) 1.65
Brazilian vaccinia viruses and their origins. Emerg Infect Dis (2007) 1.64
Norwalk virus-specific binding to oyster digestive tissues. Emerg Infect Dis (2006) 1.63
Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine. J Clin Microbiol (2003) 1.63
characterization of acute-phase humoral immunity to monkeypox: use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 North American outbreak. Clin Diagn Lab Immunol (2005) 1.62
Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health (2002) 1.61
Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults. Vaccine (2007) 1.58
Declining hepatitis A mortality in the United States during the era of hepatitis A vaccination. J Infect Dis (2008) 1.57
Replication and packaging of Norwalk virus RNA in cultured mammalian cells. Proc Natl Acad Sci U S A (2005) 1.56
Chronic liver disease mortality in the United States, 1990-1998. Hepatology (2004) 1.55
Use of an adaptation of a commercially available PCR assay aimed at diagnosis of chlamydia and gonorrhea to detect Trichomonas vaginalis in urogenital specimens. J Clin Microbiol (2006) 1.55
The value of case-based teaching vignettes in clinical microbiology rounds. Am J Clin Pathol (2014) 1.55
National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003. Prev Chronic Dis (2008) 1.55